ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Aprepitant Oral Powder for Suspension shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2026-04-08 · last update 2026-04-08

Manufacturers: Merck Sharp & Dohme LLC

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)Merck Sharp & Dohme LLCTo Be Discontinued
 —To be discontinued in approximately early-September 2026.Posted 04/08/2026
Updated 04/08/2026
Discontinued 04/08/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)